Harvey Investment CO LLC Abbott Laboratories Transaction History

Harvey Investment CO LLC

  • $836 Million
  • Q2 2024

A detailed history of Harvey Investment CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Harvey Investment CO LLC holds 231,585 shares of ABT stock, worth $26.4 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares
231,585
Previous 229,615 0.86%
Holding current value
$26.4 Million
Previous $26.1 Million 7.79%
% of portfolio
2.88%
Previous 2.94%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
BUY
$100.73 - $112.44 $198,438 - $221,506
1,970 Added 0.86%
231,585 $24.1 Million
Q1 2024

Apr 24, 2024
SELL
$109.52 - $120.96 $327,464 - $361,670
-2,990 Reduced 1.29%
229,615 $26.1 Million
Q4 2023

Jan 24, 2024
BUY
$90.19 - $110.4 $217,357 - $266,064
2,410 Added 1.05%
232,605 $25.6 Million
Q3 2023

Oct 18, 2023
SELL
$95.53 - $114.62 $92,568 - $111,066
-969 Reduced 0.42%
230,195 $22.3 Million
Q2 2023

Jul 25, 2023
SELL
$100.78 - $112.29 $20,659 - $23,019
-205 Reduced 0.09%
231,164 $25.2 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $805,390 - $947,993
8,315 Added 3.73%
231,369 $23.4 Million
Q4 2022

Jan 20, 2023
SELL
$95.06 - $111.52 $118,539 - $139,065
-1,247 Reduced 0.56%
223,054 $24.5 Million
Q3 2022

Oct 17, 2022
SELL
$96.76 - $112.03 $11,417 - $13,219
-118 Reduced 0.05%
224,301 $21.7 Million
Q2 2022

Jul 19, 2022
SELL
$102.07 - $123.37 $49,503 - $59,834
-485 Reduced 0.22%
224,419 $24.4 Million
Q1 2022

Apr 20, 2022
SELL
$114.02 - $139.04 $45,608 - $55,616
-400 Reduced 0.18%
224,904 $26.6 Million
Q4 2021

Jan 20, 2022
SELL
$115.53 - $141.46 $204,141 - $249,959
-1,767 Reduced 0.78%
225,304 $31.7 Million
Q3 2021

Nov 02, 2021
SELL
$116.66 - $129.06 $43,747 - $48,397
-375 Reduced 0.16%
227,071 $26.8 Million
Q2 2021

Jul 23, 2021
BUY
$105.79 - $124.53 $156,569 - $184,304
1,480 Added 0.65%
227,446 $26.4 Million
Q1 2021

Apr 22, 2021
SELL
$108.84 - $128.23 $610,592 - $719,370
-5,610 Reduced 2.42%
225,966 $27.1 Million
Q4 2020

Jan 21, 2021
SELL
$105.0 - $114.42 $84,945 - $92,565
-809 Reduced 0.35%
231,576 $25.4 Million
Q3 2020

Oct 29, 2020
BUY
$91.64 - $111.29 $11,913 - $14,467
130 Added 0.06%
232,385 $25.3 Million
Q2 2020

Jul 17, 2020
SELL
$76.57 - $98.0 $447,934 - $573,300
-5,850 Reduced 2.46%
232,255 $21.2 Million
Q1 2020

Apr 21, 2020
SELL
$62.82 - $91.86 $296,196 - $433,119
-4,715 Reduced 1.94%
238,105 $18.8 Million
Q4 2019

Jan 28, 2020
SELL
$78.51 - $87.4 $47,106 - $52,440
-600 Reduced 0.25%
242,820 $21.1 Million
Q3 2019

Oct 21, 2019
SELL
$81.84 - $88.74 $44,520 - $48,274
-544 Reduced 0.22%
243,420 $20.4 Million
Q2 2019

Jul 16, 2019
SELL
$72.88 - $85.0 $18,948 - $22,100
-260 Reduced 0.11%
243,964 $20.5 Million
Q1 2019

Apr 11, 2019
SELL
$66.22 - $80.06 $421,225 - $509,261
-6,361 Reduced 2.54%
244,224 $19.5 Million
Q4 2018

Jan 31, 2019
BUY
$65.56 - $74.27 $131,775 - $149,282
2,010 Added 0.81%
250,585 $18.1 Million
Q3 2018

Oct 22, 2018
BUY
$60.81 - $73.36 $146,552 - $176,797
2,410 Added 0.98%
248,575 $18.2 Million
Q2 2018

Jul 24, 2018
SELL
$57.57 - $63.54 $35,290 - $38,950
-613 Reduced 0.25%
246,165 $15 Million
Q1 2018

Apr 23, 2018
BUY
$56.27 - $63.62 $326,984 - $369,695
5,811 Added 2.41%
246,778 $14.8 Million
Q4 2017

Jan 29, 2018
SELL
$53.68 - $57.47 $141,715 - $151,720
-2,640 Reduced 1.08%
240,967 $13.8 Million
Q3 2017

Oct 18, 2017
BUY
$48.06 - $53.64 $11.7 Million - $13.1 Million
243,607
243,607 $13 Million

Others Institutions Holding ABT

# of Institutions
3,131
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Harvey Investment CO LLC Portfolio

Follow Harvey Investment CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Investment CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Investment CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email